ASMACARE STUDY. ASSESSMENT OF THE IMPACT OF AN INTERVENTION DESIGNED TO IMPROVE THE MANAGEMENT OF ASTHMA PATIENTS
Author(s)
Espinosa C1, Plaza V2, Molina J3, Ignacio J4, Garcia-Alonso F5, Cobos A6 1Novartis Farmaceutica, Barcelona, Spain; 2Hospital de Sant Pau Barcelona, Barcelona, Spain; 3C.S. Francia, Fuenlabrada, Madrid, Spain; 4Hospital General Basico Serrania, Ronda. Malaga, Spain; 5Ministerio de Sanidad y Consumo, Madrid, Spain; 6RDES- Remote Data Entry System, Barcelona, Spain
OBJECTIVES: To assess the impact of an intervention helping physicians in the management of asthma patients (APs). METHODS: A program was designed to help physicians in the management of APs that includes an education program (EP) and a computer application (CA) advising on therapeutic decisions. The EP was devoted to teach patients to distinguish worsening symptoms requiring a hospital emergency visit from those that could be self-managed, and to ensure correct self-administration/self-control of therapy. The CA implements the Spanish recommendations for the management of APs that physicians may follow at their discretion. A naturalistic, controlled, cluster-randomized study was designed to assess the long-term (one-year) impact of the intervention on health-related quality of life as measured by the St. George's Respiratory Questionnaire (SGRQ), on direct and indirect costs, and on satisfaction and clinical outcomes. We also assessed physicians’ adherence to the recommendations. Twenty-two physicians (11 GPs , 11 pneumologists) were randomly assigned to either intervention (I) or control (C = standard practice) groups, and were expected to enroll 10 adult patients with persistent asthma (ATS criteria). RESULTS: Two physicians withdrew after randomization (I:1, C:1) but before starting recruitment. A total of 200 patients ( I:100, C:100) were recruited and 173 completed the study (C: 86, I: 87). The ITT analysis showed a greater reduction of SGRQ values in group I that was significant at the 5% level or marginally non-significant (p = 0.06) depending on the method of analysis, but always clinically significant. Resource consumption and some clinical variables (such as the number of symptom-free days and nights) favored group I (p <0.05). The recommendations were adopted in about 63% of the cases but this seemed to depend on disease severity. CONCLUSIONS: The intervention improved QoL, clinical outcomes and resource consumption. The Spanish recommendations for the management of APs should be revised for severe cases.
Conference/Value in Health Info
2001-11, ISPOR Europe 2001, Cannes, France
Value in Health, Vol. 4, No. 6 (November/December 2001)
Code
PRP6
Topic
Clinical Outcomes
Topic Subcategory
Comparative Effectiveness or Efficacy
Disease
Respiratory-Related Disorders